Fuiyoh_老虎社区_美港股上老虎

pch1985
2021-08-05

Fuiyoh

Why Moderna Stock Surged to a New All-Time High Today

Mounting COVID-19 case counts could drive more people to get vaccinated. What happened Shares of Mod

Why Moderna Stock Surged to a New All-Time High Today

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":890423158,"tweetId":"890423158","gmtCreate":1628129066674,"gmtModify":1631889817166,"author":{"id":3587012057086552,"idStr":"3587012057086552","authorId":3587012057086552,"authorIdStr":"3587012057086552","name":"pch1985","avatar":"https://static.tigerbbs.com/b538f40d89f62e07590e508fd4810385","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Fuiyoh</p></body></html>","htmlText":"<html><head></head><body><p>Fuiyoh</p></body></html>","text":"Fuiyoh","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/890423158","repostId":1105353628,"repostType":4,"repost":{"id":"1105353628","pubTimestamp":1628127525,"share":"https://www.laohu8.com/m/news/1105353628?lang=&edition=full","pubTime":"2021-08-05 09:38","market":"us","language":"en","title":"Why Moderna Stock Surged to a New All-Time High Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1105353628","media":"The Motley Fool","summary":"Mounting COVID-19 case counts could drive more people to get vaccinated.\nWhat happened\nShares of Mod","content":"<p><i>Mounting COVID-19 case counts could drive more people to get vaccinated.</i></p>\n<h3><b>What happened</b></h3>\n<p>Shares of&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped 8.4% to a record closing high of $419.05 on Wednesday, as investors bid up the&nbsp;biotech's stock price ahead of its upcoming earnings announcement.</p>\n<h3><b>So what</b></h3>\n<p>Moderna said on Tuesday that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for its mRNA vaccine candidate against respiratory syncytial virus (RSV) in adults older than 60. RSV is a common respiratory virus that leads to roughly 177,000 hospitalizations and 14,000 deaths among adults 65 years and older each year, according to the U.S. Centers for Disease Control and Prevention.</p>\n<p>The Fast Track designation will accelerate the FDA's review of Moderna's drug. If the vaccine proves both safe and effective, Moderna could add a new revenue stream sooner than many investors expected.</p>\n<p><img src=\"https://static.tigerbbs.com/0b073ade8c6474ded744f2354f61f137\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">IMAGE SOURCE: GETTY IMAGES.</p>\n<p>Meanwhile, surging COVID-19 case counts, driven by the spread of the highly contagious delta variant, are leading government officials to reimpose mask-wearing mandates and other safety restrictions. New York City, for one, said it would require evidence of a coronavirus vaccination before people could work out at gyms and dine indoors at restaurants. Many businesses and universities also plan to require proof of vaccination from their employees and students.</p>\n<h3><b>Now what</b></h3>\n<p>Investors appear to be betting that these mandates will increase demand for Moderna's COVID-19 vaccine. Shareholders can expect management to provide its most up-to-date sales and earnings forecast tomorrow. Moderna is slated to hold its second-quarter earnings call at 8 a.m. EDT.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Stock Surged to a New All-Time High Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Stock Surged to a New All-Time High Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-05 09:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/04/why-moderna-stock-surged-to-a-new-all-time-high-to/><strong>The Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mounting COVID-19 case counts could drive more people to get vaccinated.\nWhat happened\nShares of Moderna, Inc. jumped 8.4% to a record closing high of $419.05 on Wednesday, as investors bid up the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/04/why-moderna-stock-surged-to-a-new-all-time-high-to/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/08/04/why-moderna-stock-surged-to-a-new-all-time-high-to/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105353628","content_text":"Mounting COVID-19 case counts could drive more people to get vaccinated.\nWhat happened\nShares of Moderna, Inc. jumped 8.4% to a record closing high of $419.05 on Wednesday, as investors bid up the biotech's stock price ahead of its upcoming earnings announcement.\nSo what\nModerna said on Tuesday that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for its mRNA vaccine candidate against respiratory syncytial virus (RSV) in adults older than 60. RSV is a common respiratory virus that leads to roughly 177,000 hospitalizations and 14,000 deaths among adults 65 years and older each year, according to the U.S. Centers for Disease Control and Prevention.\nThe Fast Track designation will accelerate the FDA's review of Moderna's drug. If the vaccine proves both safe and effective, Moderna could add a new revenue stream sooner than many investors expected.\nIMAGE SOURCE: GETTY IMAGES.\nMeanwhile, surging COVID-19 case counts, driven by the spread of the highly contagious delta variant, are leading government officials to reimpose mask-wearing mandates and other safety restrictions. New York City, for one, said it would require evidence of a coronavirus vaccination before people could work out at gyms and dine indoors at restaurants. Many businesses and universities also plan to require proof of vaccination from their employees and students.\nNow what\nInvestors appear to be betting that these mandates will increase demand for Moderna's COVID-19 vaccine. Shareholders can expect management to provide its most up-to-date sales and earnings forecast tomorrow. Moderna is slated to hold its second-quarter earnings call at 8 a.m. EDT.","news_type":1},"isVote":1,"tweetType":1,"viewCount":158,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}